Gaia Pupillo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Gaia Pupillo has a total of 221 co-authors. Here are the top co-authors by number of shared publications:
- Juan Esposito
INFN, Laboratori Nazionali di Legnaro (LNL), Via dell’Università 2, 35020 Legnaro, Italy
18 shared publications - Liliana Mou
INFN Legnaro National Laboratories, Viale dell'Università 2, Legnaro, Italy
15 shared publications - Lucia De Dominicis
Dipartimento di Fisica e Astronomia, Università degli studi di Padova, Via Marzolo 8, 35131, Padova, Italy; Istituto Nazionale di Fisica Nucleare-Laboratori Nazionali di Legnaro, Viale dell'Università 2, Legnaro, 35020, Padova, Italy
12 shared publications - Petra Martini
Department of Environmental and Prevention Sciences, University of Ferrara, 44121 Ferrara, Italy
11 shared publications - Sara Cisternino
Legnaro National Laboratories, Italian National Institute for Nuclear Physics (LNL-INFN), Viale dell’Università, 2, 35020 Legnaro (PD), Italy
11 shared publications - Alessandra Boschi
Department of Chemical, Pharmaceutical and Agricultural Sciences, University of Ferrara, Via L. Borsari, 46, 44121 Ferrara, Italy
10 shared publications
Latest Publications
- Open Access
- 23 October 2026
- Published by Elsevier in Applied Radiation and Isotopes
- Vol. 239
Assessment of the 49Ti(d,x) route to produce the theranostic radionuclide 47Sc based on cross-section measurements
- 23 October 2026
- Published by Elsevier in Applied Radiation and Isotopes
- Vol. 239
Open AccessAssessment of the 49Ti(d,x) route to produce the theranostic radionuclide 47Sc based on cross-section measurements
- 18 September 2026
- Published by Springer Nature in Journal of Radioanalytical and Nuclear Chemistry
- p. 1-9
The SPES_MED project
- 18 September 2026
- Published by Springer Nature in Journal of Radioanalytical and Nuclear Chemistry
- p. 1-9
The SPES_MED project
- 1 September 2026
- Published by AIP Publishing in Review of Scientific Instruments
- Vol. 97 (9)
Design of a variable energy linac for alpha particle acceleration and medical radioisotope production
An α-drift tube linac (DTL) is a high-performance linac conceived for radioisotope production. The use of alpha particle beams may make yielding radionuclides hard to obtain with traditional nuclear reactors or by proton accelerators, by exploiting new reaction routes. This approach may lead to better radionuclide impurity profiles, simplifying the radiochemical separation and purification process. The key idea of the α-DTL is to use a high duty cycle linac composed of an electron cyclotron resonance ion source, a radio frequency quadrupole, and a DTL, able to accelerate an average current of 0.5 mA alpha beam from few MeV to 40 MeV, to cover the cross sections of many interesting reactions for radionuclides. The innovative feature of this linac is the capability of regulating energy at the exit of the DTL, by a particular use of the stabilization system (post couplers) of the DTL cavity.
- 1 September 2026
- Published by AIP Publishing in Review of Scientific Instruments
- Vol. 97 (9)
Design of a variable energy linac for alpha particle acceleration and medical radioisotope production
An α-drift tube linac (DTL) is a high-performance linac conceived for radioisotope production. The use of alpha particle beams may make yielding radionuclides hard to obtain with traditional nuclear reactors or by proton accelerators, by exploiting new reaction routes. This approach may lead to better radionuclide impurity profiles, simplifying the radiochemical separation and purification process. The key idea of the α-DTL is to use a high duty cycle linac composed of an electron cyclotron resonance ion source, a radio frequency quadrupole, and a DTL, able to accelerate an average current of 0.5 mA alpha beam from few MeV to 40 MeV, to cover the cross sections of many interesting reactions for radionuclides. The innovative feature of this linac is the capability of regulating energy at the exit of the DTL, by a particular use of the stabilization system (post couplers) of the DTL cavity.
- Open Access
- 31 July 2026
- Published by Elsevier in SSRN Electronic Journal
Assessment of the 49Ti(d,x) route to produce the theranostic radionuclide 47Sc based on cross-section measurements
The availability of the theranostic radionuclide 47Sc is hindered by the lack of a reliable high purity production method. The aim of this work is to evaluate a less considered pathway exploiting deuteron beams on enriched 49Ti targets. The investigation started from the measurements of the production cross sections of the emergent radionuclide 47Sc, as well as of the co-produced contaminants which play an important role on the final purity and in the evaluation of the dose eventually administered to a patient. Enriched 49Ti targets, manufactured at the INFN-LNL (National Institute of Nuclear Physics-Legnaro National Laboratories), were activated in several irradiation runs carried out at the GIP ARRONAX (Group of Public Interest Accelerator for Research in Radiochemistry and Oncology in Nantes-Atlantique) facility cyclotron utilizing the tunable 15÷35 MeV deuteron beam. The obtained cross section trends, which constitute the first measurement for some radionuclides, are compared to theoretical curves and literature data, when available. The experimental cross sections are then discussed to assess 49Ti(d,x) as a possible production route for 47Sc. The results demonstrated that 49Ti(d,α)47Sc can be considered as a valid alternative production route for the supply of this medically interesting radionuclide.
- 31 July 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessAssessment of the 49Ti(d,x) route to produce the theranostic radionuclide 47Sc based on cross-section measurements
The availability of the theranostic radionuclide 47Sc is hindered by the lack of a reliable high purity production method. The aim of this work is to evaluate a less considered pathway exploiting deuteron beams on enriched 49Ti targets. The investigation started from the measurements of the production cross sections of the emergent radionuclide 47Sc, as well as of the co-produced contaminants which play an important role on the final purity and in the evaluation of the dose eventually administered to a patient. Enriched 49Ti targets, manufactured at the INFN-LNL (National Institute of Nuclear Physics-Legnaro National Laboratories), were activated in several irradiation runs carried out at the GIP ARRONAX (Group of Public Interest Accelerator for Research in Radiochemistry and Oncology in Nantes-Atlantique) facility cyclotron utilizing the tunable 15÷35 MeV deuteron beam. The obtained cross section trends, which constitute the first measurement for some radionuclides, are compared to theoretical curves and literature data, when available. The experimental cross sections are then discussed to assess 49Ti(d,x) as a possible production route for 47Sc. The results demonstrated that 49Ti(d,α)47Sc can be considered as a valid alternative production route for the supply of this medically interesting radionuclide.
- Open Access
- 28 February 2026
- Published by Elsevier in Ceramics International
- Vol. 52 (12) , 18642-18653
Optimization of the production process of gadolinium oxide targets for nuclear medicine by spark plasma sintering
- 28 February 2026
- Published by Elsevier in Ceramics International
- Vol. 52 (12) , 18642-18653
Open AccessOptimization of the production process of gadolinium oxide targets for nuclear medicine by spark plasma sintering
- Open Access
- 1 October 2025
- Published by Adjacent Digital Politics Ltd in Open Access Government
- Vol. 48 (1) , 186-187
Future innovative radionuclides for cancer treatment at INFN
Future innovative radionuclides for cancer treatment at INFN: The Italian Institute for Nuclear Physics conducts cutting-edge research in the field of nuclear, particle, and astroparticle physics, as well as in developing technologies for research and their applications to benefit society. Founded in 1951, the Italian Institute for Nuclear Physics (INFN) is the public research institute that has taken up the scientific legacy of Enrico Fermi for more than seventy years. Among the four INFN National Laboratories, the Legnaro National Laboratories (LNL, Legnaro, Padova) are internationally recognised for conducting state-of-the-art research in the field of nuclear physics and its applications, thanks to the five particle accelerators and related technologies available there.
- 1 October 2025
- Published by Adjacent Digital Politics Ltd in Open Access Government
- Vol. 48 (1) , 186-187
Open AccessFuture innovative radionuclides for cancer treatment at INFN
Future innovative radionuclides for cancer treatment at INFN: The Italian Institute for Nuclear Physics conducts cutting-edge research in the field of nuclear, particle, and astroparticle physics, as well as in developing technologies for research and their applications to benefit society. Founded in 1951, the Italian Institute for Nuclear Physics (INFN) is the public research institute that has taken up the scientific legacy of Enrico Fermi for more than seventy years. Among the four INFN National Laboratories, the Legnaro National Laboratories (LNL, Legnaro, Padova) are internationally recognised for conducting state-of-the-art research in the field of nuclear physics and its applications, thanks to the five particle accelerators and related technologies available there.
- Open Access
- 14 June 2025
- Published by Elsevier in Applied Radiation and Isotopes
- Vol. 225, 111957
Bilayer target for efficient production of 47Sc from proton-induced irradiation
- 14 June 2025
- Published by Elsevier in Applied Radiation and Isotopes
- Vol. 225, 111957
Open AccessBilayer target for efficient production of 47Sc from proton-induced irradiation
- Open Access
- 18 April 2024
- Published by Springer Nature in Journal of Radioanalytical and Nuclear Chemistry
- Vol. 333 (11) , 5979-5985
Proton-induced reactions for 47Sc (and 46Sc) production: new nuclear cross section measurements on enriched titanium targets
47Sc is a theranostic radionuclide under the spotlight of the scientific community thanks to its potential for SPECT imaging and therapeutic applications. This work presents the recent measurements of proton-induced nuclear reaction cross-sections aimed at 47Sc production using enriched 48Ti, 49Ti and 50Ti targets from 23 up to 70 MeV. Since the co-production of contaminant isotopes is a key issue, and 46Sc is the main one having a longer half-life than 47Sc, the 48/49/50Ti(p,x)47Sc and 46Sc cross sections are presented and compared with the scarce literature data and TALYS estimations.
- 18 April 2024
- Published by Springer Nature in Journal of Radioanalytical and Nuclear Chemistry
- Vol. 333 (11) , 5979-5985
Open AccessProton-induced reactions for 47Sc (and 46Sc) production: new nuclear cross section measurements on enriched titanium targets
47Sc is a theranostic radionuclide under the spotlight of the scientific community thanks to its potential for SPECT imaging and therapeutic applications. This work presents the recent measurements of proton-induced nuclear reaction cross-sections aimed at 47Sc production using enriched 48Ti, 49Ti and 50Ti targets from 23 up to 70 MeV. Since the co-production of contaminant isotopes is a key issue, and 46Sc is the main one having a longer half-life than 47Sc, the 48/49/50Ti(p,x)47Sc and 46Sc cross sections are presented and compared with the scarce literature data and TALYS estimations.
- Open Access
- 23 December 2023
- Published by MDPI AG in Pharmaceuticals
- Vol. 17 (1) , 26
Nuclear Cross-Section of Proton-Induced Reactions on Enriched 48Ti Targets for the Production of Theranostic 47Sc Radionuclide, 46cSc, 44mSc, 44gSc, 43Sc, and 48V
The cross-sections of the 48Ti(p,x)47Sc, 46cSc, 44mSc, 44gSc, 43Sc, and 48V nuclear reactions were measured from 18 to 70 MeV, with particular attention to 47Sc production. Enriched 48Ti powder was deposited on an aluminum backing and the obtained targets were characterized via elastic backscattering spectroscopy at the INFN-LNL. Targets were exposed to low-intensity proton irradiation using the stacked-foils technique at the ARRONAX facility. Activated samples were measured using γ-spectrometry; the results were compared with the data int he literature and the theoretical TALYS-based values. A regular trend in the new values obtained from the different irradiation runs was noted, as well as a good agreement with the literature data, for all the radionuclides of interest: 47Sc, 46cSc, 44mSc, 44gSc, 43Sc, and 48V. 47Sc production was also discussed, considering yield and radionuclidic purity, for different 47Sc production scenarios.
- 23 December 2023
- Published by MDPI AG in Pharmaceuticals
- Vol. 17 (1) , 26
Open AccessNuclear Cross-Section of Proton-Induced Reactions on Enriched 48Ti Targets for the Production of Theranostic 47Sc Radionuclide, 46cSc, 44mSc, 44gSc, 43Sc, and 48V
The cross-sections of the 48Ti(p,x)47Sc, 46cSc, 44mSc, 44gSc, 43Sc, and 48V nuclear reactions were measured from 18 to 70 MeV, with particular attention to 47Sc production. Enriched 48Ti powder was deposited on an aluminum backing and the obtained targets were characterized via elastic backscattering spectroscopy at the INFN-LNL. Targets were exposed to low-intensity proton irradiation using the stacked-foils technique at the ARRONAX facility. Activated samples were measured using γ-spectrometry; the results were compared with the data int he literature and the theoretical TALYS-based values. A regular trend in the new values obtained from the different irradiation runs was noted, as well as a good agreement with the literature data, for all the radionuclides of interest: 47Sc, 46cSc, 44mSc, 44gSc, 43Sc, and 48V. 47Sc production was also discussed, considering yield and radionuclidic purity, for different 47Sc production scenarios.
- Open Access
- 10 December 2023
- Published by Springer Nature in The European Physical Journal Plus
- Vol. 138 (12) , 1-13
Cyclotron-based production of innovative medical radionuclides at the INFN-LNL: state of the art and perspective
The production of medical radionuclides is one of the research activities carried out in the framework of the SPES (Selective Production of Exotic Species) project under the completion stage at the Legnaro National Laboratories of the National Institute for Nuclear Physics (INFN-LNL). The heart of SPES is the 70-MeV proton cyclotron having a dual-beam extraction, installed and commissioned in a new building equipped with ancillary laboratories currently under construction. The SPES main goal is the realization of an advanced ISOL (Isotope Separation On-Line) facility to produce re-accelerated exotic ion beams for fundamental nuclear physics studies. The cyclotron double-beam extraction system allows to simultaneously carry out applied research, such as radionuclides production for medicine (SPES- $$\gamma$$ ). This paper summarizes the results obtained with the interdisciplinary projects LARAMED (LAboratory of RAdionuclides for MEDicine) and ISOLPHARM (ISOL technique for radioPHARMaceuticals). The first one, based upon the direct activation method, is focused on the production of the radionuclides under the spotlight of the international community (e.g., $$^{99m}$$ Tc, $$^{67}$$ Cu, $$^{52/51}$$ Mn, $$^{47}$$ Sc and Tb isotopes), from the nuclear cross-section measurements up to the preclinical studies. The other one exploits the ISOL technique for the development and production of radioisotopes with high-specific activity, such as $$^{111}$$ Ag, going beyond the state of the art in the field. The most recent SPES- $$\gamma$$ research activities and future perspective are here described, characterized by a consolidated network of collaborations with national and international institutions.- 10 December 2023
- Published by Springer Nature in The European Physical Journal Plus
- Vol. 138 (12) , 1-13
Open AccessCyclotron-based production of innovative medical radionuclides at the INFN-LNL: state of the art and perspective
The production of medical radionuclides is one of the research activities carried out in the framework of the SPES (Selective Production of Exotic Species) project under the completion stage at the Legnaro National Laboratories of the National Institute for Nuclear Physics (INFN-LNL). The heart of SPES is the 70-MeV proton cyclotron having a dual-beam extraction, installed and commissioned in a new building equipped with ancillary laboratories currently under construction. The SPES main goal is the realization of an advanced ISOL (Isotope Separation On-Line) facility to produce re-accelerated exotic ion beams for fundamental nuclear physics studies. The cyclotron double-beam extraction system allows to simultaneously carry out applied research, such as radionuclides production for medicine (SPES- $$\gamma$$ ). This paper summarizes the results obtained with the interdisciplinary projects LARAMED (LAboratory of RAdionuclides for MEDicine) and ISOLPHARM (ISOL technique for radioPHARMaceuticals). The first one, based upon the direct activation method, is focused on the production of the radionuclides under the spotlight of the international community (e.g., $$^{99m}$$ Tc, $$^{67}$$ Cu, $$^{52/51}$$ Mn, $$^{47}$$ Sc and Tb isotopes), from the nuclear cross-section measurements up to the preclinical studies. The other one exploits the ISOL technique for the development and production of radioisotopes with high-specific activity, such as $$^{111}$$ Ag, going beyond the state of the art in the field. The most recent SPES- $$\gamma$$ research activities and future perspective are here described, characterized by a consolidated network of collaborations with national and international institutions.